Pediatric Unanticipated Admission Incidence 0.97 Percent

This article originally appeared here.
Share this content:
Pediatric Unanticipated Admission Incidence 0.97 Percent
Pediatric Unanticipated Admission Incidence 0.97 Percent

FRIDAY, June 10, 2016 (HealthDay News) -- The incidence of pediatric unanticipated admissions is 0.97 percent, with about half of admissions related to anesthesia, according to a study published online June 1 in Pediatric Anesthesia.

Amanda Whippey, M.D., from McMaster University in Hamilton, Canada, and colleagues compared pediatric patients undergoing ambulatory surgery and requiring unanticipated admission between 2005 and 2013 with a random sample of pediatric patients not requiring admission. They collected data on demographics, surgical information, medications, intraoperative events, and patient comorbidities from both groups.

The researchers found that the incidence of unanticipated admission was 0.97 percent, and 47 percent of cases were anesthesia-related. Factors associated with unanticipated admission included age younger than 2 years (odds ratio, 4.26); American Society of Anesthesiologists (ASA) 3 class (odds ratio, 3.77); duration of surgery above one hour (odds ratio, 6.54); completion of surgery after 3 p.m. (odds ratio, 2.17); orthopedic, dental, or ear, nose, and throat (ENT) surgery (odds ratios, 2.52, 0.21, and 6.47, respectively); intraoperative events (odds ratio, 4.45); and obstructive sleep apnea (OSA; odds ratio, 6.32).

"The incidence of unanticipated admission in children following ambulatory surgery is low. Age, ASA class, duration, and time of completion of surgery are predictors common to pediatrics and adults," the authors write. "Interestingly, intraoperative complications, OSA, and type of surgery (ENT, orthopedic, dental) are specific to pediatrics."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »